Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility

Endocrinology

Volumn 142, Issue 2, 2001, Pages 623-632

  Zhao, G ^a   Sutliff, R L ^a   Weber, C S ^a   Wang, J ^a   Lorenz, J ^a   Paul, R J ^a   Fagin, J A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CONTRACTILE PROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; N(G) NITROARGININE; PHENYLEPHRINE; POTASSIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DEPOLARIZATION; DESENSITIZATION; GENE OVEREXPRESSION; HEART RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY;

EID: 0035106356     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.2.7941     Document Type: Article

References (45)

1. Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C
2. Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells
3. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
4. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity
5. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation
6. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat
7. Increase in insulin-like growth factor I in hypertrophying smooth muscle
8. Estrogen induction of insulin-like growth factors and myc proto-oncogene expression in the uterus
9. Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus
10. Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: Tissue localization and IGF-I action in endometrial stromal and myo I metrial smooth muscle cells in vitro
11. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice
12. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix
13. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5
14. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: Evidence for processing of cell-bound IGFBP-3
15. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
16. Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4
17. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells
18. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
19. Recombinant human insulin-like growth factorincreases forearm blood flow
20. Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats
21. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide
22. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle
23. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro
24. Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production
25. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells
26. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells
27. Insulin response to oral glucose in essential hypertensives with increased circulating levels of insulin growth factor I
28. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta
29. Expression of IGF-1, IGF-receptor and TGF-beta following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study
30. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle
31. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: Evidence for endothelium involvement independent of nitric oxide formation
32. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
33. Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos
34. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase
35. C-terminal isoforms of the myosin heavy chain and smooth muscle function
36. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature
37. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring
38. Normal growth and development in the absence of hepatic insulin-like growth factor I
39. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: Implications in vascular hyperplasia
40. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I
41. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
42. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r)
43. Correlations between myosin heavy chain isoforms and mechanical parameters in rat myometrium
44. Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice
45. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis